Background Cases of human monkeypox are rarely seen outside of west and central Africa.
There are few data regarding viral kinetics or the duration of viral shedding and no licensed …

Antibody responses to SARS-CoV-2 can be detected in most infected individuals 10–15 d
after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS-CoV-…

Currently, no vaccine exists for hepatitis C virus (HCV), a major pathogen thought to infect
170 million people globally. Many studies suggest that host T cell responses are critical for …

Induction of antigen-specific CD8 + T cells offers the prospect of immunization against many
infectious diseases, but no subunit vaccine has induced CD8 + T cells that correlate with …

Replication-defective adenovirus vectors based on human serotype 5 (Ad5) induce protective
immune responses against diverse pathogens and cancer in animal models, as well as …

Background. Vaccine development in human Plasmodium falciparum malaria has been
hampered by the exceptionally high levels of CD8 + T cells required for efficacy. Use of potently …

The difficulty of inducing protective immunity through antibodies against sporozoites led to
efforts to assess vectored vaccines as a means of inducing protective T cell immunity against …

Background The scale of the 2022 global mpox (formerly known as monkeypox) outbreak
has been unprecedented. In less than 6 months, non-endemic countries have reported more …

Background Traditionally, vaccine development against the blood-stage of Plasmodium
falciparum infection has focused on recombinant protein-adjuvant formulations in order to …

There is a clear requirement for an accurate SARS-CoV-2 antibody test, both as a complement
to existing diagnostic capabilities and for determining community seroprevalence. We …